Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vital Signs buy IP holder for C-CO2 indicator:

This article was originally published in Clinica

Executive Summary

Vital Signs' Swedish subsidiary, Vital Signs Sweden, has acquired fellow Swedish company Futall, which holds the intellectual property rights underlying its C-CO2 indicator, for approximately $2m. The acquisition will enable Vital Signs Sweden to manufacture products similar to C-CO2 for other companies on an OEM basis. The C-CO2 is designed to guard against the accidental insertion of a tracheal tube into the oesophagus by detecting the presence of carbon dioxide in exhaled gas.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT058092

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel